The Cigna Group Reports Q3 2026 Results and Raises Full-Year Guidance

Executive Summary

On November 5, 2026, The Cigna Group (NYSE: CI) filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), furnishing its third-quarter 2026 financial results via Exhibit 99.1.

Financial Highlights

• Total Revenues: Reached $73.68 billion, up 6% compared to $69.75 billion in Q3 2025. Adjusted revenues reached $73.79 billion versus $69.57 billion in the prior-year period.
• GAAP Net Income: Shareholders' net income was $1.44 billion ($5.47 per share), compared to $1.87 billion ($6.98 per share) in Q3 2025, primarily due to the absence of an after-tax gain on sale recorded in Q3 2025.
• Adjusted Income from Operations: Rose to $2.10 billion, or $7.98 per share, compared with $2.10 billion, or $7.83 per share, in Q3 2025.
• Expense & Leverage Ratios:
  • Adjusted SG&A expense ratio was 4.7% compared to 4.6% in Q3 2025.
  • Debt-to-capitalization improved to 41.8% as of September 30, 2026, down from 44.9% at September 30, 2025.
• Capital Return: Year-to-date through November 4, 2026, the company repurchased 1.8 million shares of common stock for approximately $500 million.

Strategic Updates & Guidance

• Guidance Increase: Full-year 2026 adjusted income from operations outlook raised to at least $30.60 per share.
• Investor Day Announcements: Unveiled the 'Lead to One' strategy targeting a 10%–14% adjusted EPS CAGR and ~$50 billion in cumulative operating cash flow through 2030, alongside 'Accelerate to One', a multi-year $3 billion modernization and productivity program.